Victory Capital Management Inc. Has $8.75 Million Position in Teleflex Incorporated (NYSE:TFX)

Victory Capital Management Inc. lifted its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 364.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,370 shares of the medical technology company's stock after purchasing an additional 27,757 shares during the quarter. Victory Capital Management Inc. owned 0.08% of Teleflex worth $8,748,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Aigen Investment Management LP increased its holdings in shares of Teleflex by 33.2% in the third quarter. Aigen Investment Management LP now owns 2,883 shares of the medical technology company's stock valued at $713,000 after purchasing an additional 718 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Teleflex by 2.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 102,909 shares of the medical technology company's stock worth $25,451,000 after acquiring an additional 2,545 shares during the last quarter. Apollon Wealth Management LLC lifted its stake in shares of Teleflex by 3.7% during the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company's stock valued at $377,000 after acquiring an additional 55 shares during the period. Ashton Thomas Securities LLC bought a new position in Teleflex in the third quarter valued at about $40,000. Finally, Verdence Capital Advisors LLC boosted its holdings in Teleflex by 6.4% in the third quarter. Verdence Capital Advisors LLC now owns 1,622 shares of the medical technology company's stock valued at $401,000 after acquiring an additional 97 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Price Performance

Shares of TFX traded up $1.07 during trading hours on Friday, hitting $191.71. 309,405 shares of the company were exchanged, compared to its average volume of 379,870. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a fifty-two week low of $185.66 and a fifty-two week high of $257.85. The company has a market cap of $8.90 billion, a price-to-earnings ratio of 37.87, a P/E/G ratio of 1.98 and a beta of 1.18. The firm's fifty day moving average is $226.07 and its 200 day moving average is $222.79.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. The firm had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company's revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the business posted $3.64 EPS. On average, equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be given a $0.34 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.71%. Teleflex's dividend payout ratio is currently 27.04%.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Truist Financial reissued a "hold" rating and issued a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Monday, November 4th. StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Wednesday. Finally, Royal Bank of Canada lowered their price target on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $259.25.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.